Meetings:

Federal Register Volume 76, Number 193 (Wednesday, October 5, 2011)

Notices

Pages 61722-61723

From the Federal Register Online via the Government Printing Office [www.gpo.gov]

FR Doc No: 2011-25635

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

National Heart, Lung, and Blood Institute; Notice of Closed

Meetings

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5

U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Heart, Lung, and Blood Institute

Special Emphasis Panel, Data Coordinating Center for the

Cardiovascular Cell Therapy Research Network.

Date: October 24, 2011.

Time: 8 a.m. to 9:30 a.m.

Agenda: To review and evaluate grant applications.

Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400

Wisconsin Avenue, Bethesda, MD 20814.

Contact Person: Kristin Goltry, PhD, Scientific Review Officer,

Review Branch, DERA, National Heart, Lung, and Blood Institute, 6701

Rockledge Drive, Room 7198,

Page 61723

Bethesda, MD 20892, 301-435-0297, goltrykl@mail.nih.gov.

Name of Committee: National Heart, Lung, and Blood Institute

Special Emphasis Panel, Regional Clinical Center for the

Cardiovascular Cell Therapy Research Network.

Date: October 24-25, 2011.

Time: 9:30 a.m. to 5 p.m.

Agenda: To review and evaluate grant applications.

Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400

Wisconsin Avenue, Bethesda, MD 20814.

Contact Person: Kristin Goltry, PhD, Scientific Review Officer,

Review Branch, DERA, National Heart, Lung, and Blood Institute, 6701

Rockledge Drive, Room 7198, Bethesda, MD 20892, 301-435-0297, goltrykl@mail.nih.gov.

Name of Committee: National Heart, Lung, and Blood Institute

Special Emphasis Panel, Protein Capture Agents for Cardiovascular

Research.

Date: October 24, 2011.

Time: 1 p.m. to 3 p.m.

Agenda: To review and evaluate contract proposals.

Place National Institutes of Health, 6701 Rockledge Drive,

Bethesda, MD 20892, (Telephone Conference Call).

Contact Person: David A Wilson, PhD, Scientific Review Officer,

Office of Scientific Review/DERA, National Heart, Lung, and Blood

Institute, 6701 Rockledge Drive, Room 7204, Bethesda, MD 20892-7924, 301-435-0299, wilsonda2@nhlbi.nih.gov.

Name of Committee: National Heart, Lung, and Blood Institute

Special Emphasis Panel, Translational Programs in Lung Diseases.

Date: October 26-27, 2011.

Time: 6 p.m. to 5 p.m.

Agenda: To review and evaluate grant applications.

Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400

Wisconsin Avenue, Bethesda, MD 20814.

Contact Person: Susan Wohler Sunnarborg, PhD, Scientific Review

Officer, Office of Scientific Review/DERA, National, Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7185, Bethesda, MD 20892, sunnarborgsw@nhlbi.nih.gov.

Name of Comittee: National Heart, Lung, and Blood Institute

Special Emphasis Panel, Genomic Research in AAT-Deficiency and

Sarcoidosis--Clinical Centers.

Date: October 26-27, 2011.

Time: 12:30 p.m. to 9 a.m.

Agenda: To review and evaluate grant applications.

Place: Churchill Hotel, 1914 Connecticut Avenue, NW.,

Washington, DC 20009.

Contact Person: William J. Johnson, PhD, Scientific Review

Officer, Office of Scientific Review/DERA, National Heart, Lung, and

Blood Institute, 6701 Rockledge Drive, Room 7178, Bethesda, MD 20892-7924, 301-435-0725, johnsonwj@nhlbi.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.233,

National Center for Sleep Disorders Research; 93.837, Heart and

Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839,

Blood Diseases and Resources Research, National Institutes of

Health, HHS)

Dated: September 28, 2011.

Jennifer S. Spaeth,

Director, Office of Federal Advisory Committee Policy.

FR Doc. 2011-25635 Filed 10-4-11; 8:45 am

BILLING CODE 4140-01-P

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT